These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3074228)

  • 1. Monitoring and treatment of minimal residual cancer of the prostate.
    Mathé G; Schally AV; Comaru-Schally AM; Mauvernay RY; Vovan ML; Machover D; Misset JL; Court B; Bouchard P; Duchier J
    Suppl J Med Oncol Tumor Pharmacother; 1988; 1():65-74. PubMed ID: 3074228
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring and treatment of minimal residual cancer of the prostate.
    Mathé G; Schally AV; Comaru-Schally AM; Mauvernay RY; Vovan ML; Machover D; Misset JL; Court B; Bouchard P; Duchier J
    Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):65-74. PubMed ID: 2525968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of lipid-associated sialic acid (LSA) and prostate specific antigen (PSA) in the follow-up of prostatic cancer.
    Meyer U; Dierig C; Katopodis N; De Bruijn CH
    Anticancer Res; 1993; 13(5C):1889-94. PubMed ID: 7505544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumors.
    Musset M; Mathé G; Reizenstein P
    Suppl J Med Oncol Tumor Pharmacother; 1988; 1():17-20. PubMed ID: 3249552
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumors.
    Musset M; Mathé G; Reizenstein P
    Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):17-20. PubMed ID: 2663215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostatic cancer in a young adult: a report of 2 cases].
    Sasaki H; Miki J; Hasegawa T; Hasegawa N; Ikemoto I; Ohishi Y
    Hinyokika Kiyo; 2004 Jan; 50(1):57-9. PubMed ID: 15032019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
    Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
    Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for adenocarcinoma of the prostate.
    Miles BJ
    Henry Ford Hosp Med J; 1989; 37(1):5-7. PubMed ID: 2475458
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical study on adenocarcinoma of the prostate].
    Mikata N; Imao S; Komatsu H
    Hinyokika Kiyo; 1993 Oct; 39(10):913-7. PubMed ID: 8266854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokeratin (AE1/AE3) in addition to alpha-methylacyl coenzyme A racemase (P504S), 34-beta-E12, and p63 stains in evaluation of surgical specimens after hormonal therapy for prostatic adenocarcinoma.
    Raspollini MR
    Hum Pathol; 2008 Feb; 39(2):304-5; author reply 305-6. PubMed ID: 18206500
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression of prostate cancer induced bone remodeling by the endothelin receptor A antagonist atrasentan.
    Nelson JB; Nabulsi AA; Vogelzang NJ; Breul J; Zonnenberg BA; Daliani DD; Schulman CC; Carducci MA
    J Urol; 2003 Mar; 169(3):1143-9. PubMed ID: 12576870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer metastasis to supraclavicular lymph node.
    Hobdy EM; Shafi NQ; Kummar S
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):223-4; discussion 224. PubMed ID: 16163185
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adenocarcinoma of prostate in adolescents and young adults. Apropos of a case in a 20-year-old man].
    Briet S; Trémeaux JC; Piard F; Striffling V
    J Urol (Paris); 1986; 92(8):565-8. PubMed ID: 3805751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prostate, cancer and lost patients].
    Nau JY
    Rev Med Suisse; 2012 May; 8(343):1186-7. PubMed ID: 22737953
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of primary transitional cell carcinoma of the prostate].
    Morikawa H; Cho M; Takada S; Fujimoto K; Uemura H; Ozono S; Hirao Y; Natsume O
    Hinyokika Kiyo; 2003 Jun; 49(6):357-60. PubMed ID: 12894737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An atypical course of prostatic cancer in young patients].
    Budiak VA; Chudnyĭ AI; Soloveĭ PF; Vasilevitskaia AG; Fishman MM
    Vrach Delo; 1991 Dec; (12):94-6. PubMed ID: 1792791
    [No Abstract]   [Full Text] [Related]  

  • 17. Adenocarcinoma of the prostate gland.
    Boxer RJ
    Urol Surv; 1977 Jun; 27(3):75-94. PubMed ID: 331648
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnostic value of tissue and serum prostate specific antigen in prostate cancer].
    Medvedev VL
    Voen Med Zh; 2004 Feb; 325(2):50-4. PubMed ID: 15101295
    [No Abstract]   [Full Text] [Related]  

  • 19. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
    Blana A; Walter B; Rogenhofer S; Wieland WF
    Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endometrioid adenocarcinoma of the prostate: report of 3 cases].
    Uemura M; Nakagawa M; Kanno N; Nishimura K; Miyoshi S; Kawano K
    Hinyokika Kiyo; 2004 Nov; 50(11):825-8. PubMed ID: 15628548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.